Chengdu Kanghua Biological Products Tangible Net Worth Ratio
Chengdu Kanghua Biological Products tangible net worth ratio. Chengdu Kanghua Biological Products (300841) has a Tangible Net Worth Ratio of 99.5% as of September 2025. This metric is calculated by deducting intangible assets (CN¥15.89 Million) from net assets (CN¥3.51 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Check 300841 capital-intensive asset ratio to assess the company's strategic physical and investment asset allocation.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Tangible Net Worth Ratio of Chengdu Kanghua Biological Products (2017–2024)
Tangible net worth ratio of Chengdu Kanghua Biological Products from 2017 to 2024. This chart shows how Chengdu Kanghua Biological Products's Tangible Net Worth Ratio has changed across 8 annual periods from 2017 to 2024. As of September 2025, the ratio stands at 99.5%, reflecting net assets of CN¥3.51 Billion with intangible assets of CN¥15.89 Million CNY. See Chengdu Kanghua Biological Products (300841) working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Chengdu Kanghua Biological Products Tangible Net Worth Ratio by Year (2017–2024)
Chengdu Kanghua Biological Products tangible net worth ratio by year from 2017 to 2024. The table below presents the year-by-year Tangible Net Worth Ratio for Chengdu Kanghua Biological Products from 2017 to 2024, covering 8 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For live market cap and overall valuation, see 300841 market cap.
| Year | Tangible NW Ratio | Net Assets (CNY) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 99.5% | CN¥3.45 Billion | CN¥17.51 Million | CN¥4.03 Billion | ▼ -0.1 pp |
| 2023 | 99.6% | CN¥3.51 Billion | CN¥15.38 Million | CN¥4.21 Billion | ▲ +0.1 pp |
| 2022 | 99.4% | CN¥3.08 Billion | CN¥17.23 Million | CN¥3.71 Billion | ▲ +0.1 pp |
| 2021 | 99.3% | CN¥2.67 Billion | CN¥18.77 Million | CN¥3.02 Billion | ▲ +0.4 pp |
| 2020 | 98.9% | CN¥1.97 Billion | CN¥21.75 Million | CN¥2.15 Billion | ▲ +0.5 pp |
| 2019 | 98.4% | CN¥574.65 Million | CN¥9.12 Million | CN¥689.14 Million | ▲ +1.6 pp |
| 2018 | 96.8% | CN¥367.70 Million | CN¥11.61 Million | CN¥486.07 Million | ▲ +3.8 pp |
| 2017 | 93.0% | CN¥188.37 Million | CN¥13.19 Million | CN¥274.74 Million | — |